Croatia Pharmaceuticals & Healthcare Q4 2018
Innovative pharmaceutical firms will find the Croatian market challenging in the coming years. Despite Croatia being arelatively attractive destination for investment, high labour costs compared to some regional peers and a limited availability of skilledworkers - due to a small population size and a lack of science and engineering graduates - will deter foreign multinationalinvestments. Furthermore, sales of high-value medicines will continue to be restricted by healthcare funding issues and aggressivegovernment cost-containment policies targeting the pharmaceutical sector. Multinational activity in Croatia will thus remain limitedto clinical trials and marketing activities through representative offices.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook